Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000

American Journal of Psychiatry

Volumn 160, Issue 4, 2003, Pages 757-764

  Martin, Andrés ^a   Leslie, Douglas ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADJUSTMENT DISORDER; ADOLESCENT; ANXIETY DISORDER; ARTICLE; CHILD; COST UTILITY ANALYSIS; DATA ANALYSIS; DEPRESSION; HEALTH INSURANCE; HOSPITAL PATIENT; HUMAN; HYPERACTIVITY; MENTAL DISEASE; MENTAL HEALTH SERVICE; OUTPATIENT CARE; PRIORITY JOURNAL; REIMBURSEMENT; AGE; AMBULATORY CARE; CHILD HEALTH CARE; DRUG COST; DRUG UTILIZATION; ECONOMICS; EPIDEMIOLOGY; FEMALE; HEALTH CARE COST; HOSPITALIZATION; LENGTH OF STAY; MALE; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; AGE FACTORS; AMBULATORY CARE; CHILD; DRUG COSTS; DRUG UTILIZATION; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HOSPITALIZATION; HUMANS; INSURANCE, PSYCHIATRIC; LENGTH OF STAY; MALE; MANAGED CARE PROGRAMS; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PSYCHOTROPIC DRUGS; UNITED STATES; UTILIZATION REVIEW;

EID: 0038811895     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.4.757     Document Type: Article

References (25)

1. Mental Health: A Report of the Surgeon General. Rockville, Md, US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, 1999
2. Burns BJ: Mental health service use by adolescents in the 1970s and 1980s. J Am Acad Child Adolesc Psychiatry 1991; 30:144-150
3. Ringel J, Sturm R: National estimates of mental health utilization and expenditures for children in 1998. J Behav Health Serv Res 2001; 28:319-333
4. Leslie DL, Rosenheck RA, Horwitz SM: Patterns of mental health utilization and costs among children in a privately insured population. Health Serv Res 2001; 36(1, part 1):113-127
5. Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA: Psychotherapeutic medication patterns for youths with attention-deficit/ hyperactivity disorder. Arch Pediatr Adolesc Med 1999; 153:1257-1263
6. Owens PL, Hoagwood K, Horwitz SM, Leaf PJ, Poduska JM, Kellam SG, lalongo NS: Barriers to children's mental health services. J Am Acad Child Adolesc Psychiatry 2002; 41:731-738
7. Leaf PJ, Alegria M, Cohen P, Goodman SH, Horwitz SM, Hoven CW, Narrow WE, Vaden-Kiernan M, Regier DA: Mental health service use in the community and schools: results from the four-community MECA Study (Methods for the Epidemiology of Child and Adolescent Mental Disorders Study). J Am Acad Child Adolesc Psychiatry 1996; 35:889-897
8. Burns BJ, Costello EJ, Angold A, Tweed D, Stangl D, Farmer EM, Erkanli A: Children's mental health service use across service sectors. Health Aff (Millwood) 1995; 14:147-159
9. dosReis S, Zito JM, Safer DJ, Soeken KL: Mental health services for youths in foster care and disabled youths. Am J Public Health 2001; 91:1094-1099
10. Jensen PS, Bhatara VS, Vitiello B, Hoagwood K, Feil M, Burke LB: Psychoactive medication prescribing practices for US children: gaps between research and clinical practice. J Am Acad Child Adolesc Psychiatry 1999; 38:557-565
11. Zito JM, Safer DJ, DosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA: Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 2003; 157:17-25
12. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F: Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000; 283:1025-1030
13. Riddle MA, Kastelic EA, Frosch E: Pediatric psychopharmacology. J Child Psychol Psychiatry 2001; 42:73-90
14. Vitiello B: Psychopharmacology for young children: clinical needs and research opportunities. Pediatrics 2001; 108:983-989
15. Frank RG, Brookmeyer R: Managed mental health care and patterns of inpatient utilization for treatment of affective disorders. Soc Psychiatry Psychiatr Epidemiol 1995; 30:220-223
16. Leslie DL, Rosenheck R: Shifting to outpatient care? mental health care use and cost under private insurance. Am J Psychiatry 1999; 156:1250-1257
17. Martin A, Van Hoof T, Stubbe D, Sherwin T, Scahill L: Multiple psychotropic pharmacotherapy in child and adolescent enrollees in Connecticut Medicaid managed care. Psychiatr Serv 2003; 54:72-77
18. Martin A, Sherwin T, Stubbe D, Van Hoof T, Scahill L, Leslie D: Datapoints: use of multiple psychotropic drugs by Medicaid-insured and privately insured children. Psychiatr Serv 2002; 53:1508
19. Duan N: Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1982; 78:605-610
20. Duan N, Manning WG, Morris CN, Newhouse JP: A comparison of alternative models for the demand for medical care. J Business and Economic Statistics 1983; 1:115-126
21. Olfson M, Marcus SC, Pincus HA: Trends in office-based psychiatric practice. Am J Psychiatry 1999; 156:451-457
22. Goldman W, McCulloch J, Sturm R: Costs and use of mental health services before and after managed care. Health Aff (Millwood) 1998; 17:40-52
23. Emslie GJ, Rush AJ, Weinberg WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997; 54:1031-1037
24. Research Unit on Pediatric Psychopharmacology Anxiety Study Group: Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001; 344:1279-1285
25. Wilkes MS, Bell RA, Kravitz RL: Direct-to-consumer prescription drug advertising: trends, impact, and implications. Health Aff (Millwood) 2000; 19:110-128